Funding will go toward biologic research for orthopedic diseases, with a special focus on platelet-rich plasma and growth factor injections for rotator cuff tears and knee osteoarthritis.
Research evaluating the effect of tobacco, vaping and marijuana use on postoperative outcomes for total joint replacement and the effectiveness of antibiotic bone cement for prevention of periprosthetic joint infections will also be prioritized.
AAOS made the first investment to kickstart the fund.
More articles on orthopedics:
Geoff Martha, Kevin Lobo & more: 5 CEOs to know in the spine industry
Wright Medical inches toward sale, makes pay cuts due to pandemic: 5 updates
How COVID-19 has affected Medtronic, Stryker, Johnson & Johnson’s shares over the last month
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
